Little Green PharmaASX:LGP Receivables Turnover is 5.22 as of Mar. 2026. The stock has 3 warning signs investors should review. Among 950 Drug Manufacturers companies, Little Green Pharma ranks better than 87.05% on this metric.
The Receivables Turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by average Accounts Receivable. An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. Little Green Pharma's Revenue for the
six
months ended in Mar. 2026 was A$23.24 Mil. Little Green Pharma's average Accounts Receivable for the
six
months ended in Mar. 2026 was A$4.45 Mil.
Hence, Little Green Pharma's Receivables Turnover for the
six
months ended in Mar. 2026 was 5.22.
Little Green Pharma (ASX:LGP) Receivables Turnover Explanation
An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. This metric is commonly used to compare companies within the same industry to check whether they are on par with their competitors.
Little Green Pharma Receivables Turnover Related Terms
Little Green Pharma Receivables Turnover Historical Data
* Premium members only.
The historical data trend for Little Green Pharma's Receivables Turnover can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ASX:LGP vs ZTS, UTHR: Receivables Turnover Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Little Green Pharma's Receivables Turnover, along with its competitors' market caps and Receivables Turnover data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Little Green Pharma Receivables Turnover vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Little Green Pharma's Receivables Turnover distribution charts can be found below:
* The bar in red indicates where Little Green Pharma's Receivables Turnover falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Little Green Pharma (ASX:LGP) has a Receivables Turnover of 5.22 as of Mar. 2026. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on Little Green Pharma and its competitors. According to the industry distribution chart, Little Green Pharma ranks #123 out of 950 companies in the Drug Manufacturers industry, placing it in the top 12.9%.
Is Little Green Pharma's Receivables Turnover too high?
Little Green Pharma's current Receivables Turnover is 5.22. The Drug Manufacturers industry median Receivables Turnover is 5.07. Little Green Pharma's value of 5.22 is 3% above this industry median. Based on the distribution chart, Little Green Pharma ranks #123 out of 950 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers.
How does Little Green Pharma's Receivables Turnover compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Little Green Pharma ranks #123 out of 950 companies for Receivables Turnover. This places Little Green Pharma in the top 13% of its industry — outperforming the majority of peers. The industry median Receivables Turnover is 5.07. Little Green Pharma's value of 5.22 is 3% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Receivables Turnover for a Drug Manufacturers company?
The median Receivables Turnover among Drug Manufacturers companies is 5.07, based on 950 companies in the industry. Companies in the top quartile (top 25%) have a Receivables Turnover significantly above this median, while those in the bottom quartile fall well below. However, Receivables Turnover should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Little Green Pharma's current Receivables Turnover of 5.22 is 3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Receivables Turnover mean?
A high Receivables Turnover can signal that a stock is expensive relative to its fundamentals. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on Little Green Pharma and its competitors. For the Drug Manufacturers industry, the median Receivables Turnover is 5.07 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Little Green Pharma's current Receivables Turnover is 5.22. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Little Green Pharma stock overvalued right now?
Based on GuruFocus' analysis, Little Green Pharma (ASX:LGP) is currently considered Significantly Undervalued. The stock's GF Value™ is A$0.17, compared to a current price of A$0.07 — trading 58.8% below its estimated fair value. The current Receivables Turnover is 5.22 and 3% above the Drug Manufacturers industry median of 5.07. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Receivables Turnover calculated?
Receivables Turnover is calculated from a company's financial statements. For Little Green Pharma (ASX:LGP), the current Receivables Turnover is 5.22 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Little Green Pharma Ltd is engaged in the vertically integrated medicinal cannabis business. The business activities of the company include cultivation, production, research and development, manufacturing, and distribution of medicinal cannabis products. The company's two key types of products available at Little Green Pharma are oils (which are ingested) and flowers (which are usually inhaled through vaporizing). It offers LGP-branded medicinal cannabis oil products in the Australian and European markets. The Group is organized into two operating segments: Australia and Europe (cultivation, production and distribution of cannabis products to Australian and European customers).
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ASX:LGP has been successfully added to your 